Hyperpolarized Carbon C 13 Pyruvate Clinical Trials
5 recruitingDrug
Phase 14Phase 21
Showing 1–5 of 5 trials
Recruiting
Phase 1
Hyperpolarized Imaging in Diagnosing Participants With Glioma
Glioma
Susan Chang140 enrolled1 locationNCT03739411
Recruiting
Phase 2
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Prostate CancerProstate Adenocarcinoma
University of California, San Francisco60 enrolled1 locationNCT03933670
Recruiting
Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
Primary Brain Neoplasm
M.D. Anderson Cancer Center13 enrolled1 locationNCT03830151
Recruiting
Phase 1
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Thyroid Gland Carcinoma
M.D. Anderson Cancer Center42 enrolled1 locationNCT04589624
Recruiting
Phase 1
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
WHO Grade III GliomaWHO Grade II GliomaRecurrent WHO Grade III Glioma+1 more
Susan Chang300 enrolled1 locationNCT04540107